VAERS reports by lot

GSK Hepatitis A lot 92DJ3: VAERS reports

25 VAERS reports list lot 92DJ3 as a GSK Hepatitis A vaccine, received between 2023-09-06 and 2025-07-08. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
25
Reports
0%
Marked serious
0
With a death outcome
15
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological433%
Gastrointestinal217%
Dermatological (non-injection-site)217%
Injection-site / Local reaction217%
Respiratory18%
Psychiatric / Neuropsychiatric18%

Where reports came from

U.S. state of the reporter, where given (top 12).

StateReports
California6
North Carolina2
Georgia2
Illinois2
Arizona2
Texas1
New York1
Indiana1
New Jersey1
Minnesota1
Colorado1
Oregon1

Reports by month received

MonthReportsBar
2023-092
2023-101
2023-112
2024-021
2024-031
2024-042
2024-052
2024-062
2024-082
2024-092
2024-111
2024-121
2025-021
2025-054
2025-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Nearby GSK Hepatitis A lots (A–Z): 7NX57 · 7YA99 · 9255P · 95BJ9 · 95DB2 · 95EJ7

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.